2 Bay Area Biotechs That Jumped While Its Peers Cratered Post author:Sam Post published:February 6, 2018 Post category:BioPharma Since Friday, the stock market has been volatile, to say the least. Source: BioSpace You Might Also Like Takeda Splits Off a Range of Businesses to Focus on R&D April 6, 2017 AstraZeneca PLC Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial February 16, 2017 Zynerba Release: Company Announces Proposed Public Offering Of Common Stock January 18, 2017
AstraZeneca PLC Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial February 16, 2017
